DEVON HOEPFNER: Open Payments
NPI 1588342406 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$973 in 56 payments from 7 companies in 2025. Trend: 2023 $327 · 2024 $512 · 2025 $973
Food & beverage: $973
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $385 |
| Vanda Pharmaceuticals Inc. | 8 | $244 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $132 |
| Janssen Pharmaceuticals, Inc | 3 | $100 |
| Otsuka America Pharmaceutical, Inc. | 3 | $79 |
| Lundbeck LLC | 1 | $18 |
| Noven Therapeutics, LLC | 1 | $15 |
Products named: VRAYLAR, FANAPT, CAPLYTA, SPRAVATO, REXULTI, Xelstrym.
Industry payments across AZ — which companies pay providers there.
